Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16ink4A and p21WAF/Cip1 by distinct mechanisms

被引:99
作者
Fournel, M [1 ]
Sapieha, P [1 ]
Beaulieu, N [1 ]
Besterman, JM [1 ]
MacLeod, AR [1 ]
机构
[1] MethylGene Inc, Montreal, PQ H4S 2A1, Canada
关键词
D O I
10.1074/jbc.274.34.24250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A common event in the development of human neoplasia is the loss of growth regulatory tumor suppressor functions. Methylation of 5' CpG islands of tumor suppressor genes and elevated levels of the DNA-(cytosine-5)-methyltransferase enzyme (DNA MeTase) are also prevalent features of human neoplasia, However, direct evidence that elevated DNA MeTase levels alter gene expression and influence oncogenesis has been difficult to obtain, in part due to the lack of specific DNA MeTase inhibitors. Here we show that specific reduction of cellular DNA MeTase levels in human cancer cells with potent antisense inhibitors: 1) causes demethylation of the p16(ink4A) gene promoter; 2) causes re-expression of the p16(ink4A) protein; 3) leads to accumulation of the hypophosphorylated form of the retinoblastoma protein (pRb); and 4) inhibits cell proliferation. Stepwise reduction of cellular DNA MeTase protein levels also induced a corresponding rapid increase in the cell cycle regulator p21(WAF/Cip1) protein demonstrating a regulatory link between DNA MeTase and the growth regulator p21(WAF/Cip1) that is independent of methylation of DNA. These results suggest that the elevated levels of DNA MeTase seen in cancer cells can inhibit tumor suppressors by distinct mechanisms involving either transcriptional inactivation through DNA methylation or by a methylation independent regulation.
引用
收藏
页码:24250 / 24256
页数:7
相关论文
共 52 条
  • [1] MOUSE DNA METHYLASE - METHYLATION OF NATIVE DNA
    ADAMS, RLP
    MCKAY, EL
    CRAIG, LM
    BURDON, RH
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 561 (02) : 345 - 357
  • [2] Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies
    Baghdassarian, N
    Ffrench, M
    [J]. HEMATOLOGY AND CELL THERAPY, 1996, 38 (04): : 313 - 323
  • [3] Role of DNA 5-methylcytosine transferase in cell transformation by fos
    Bakin, AV
    Curran, T
    [J]. SCIENCE, 1999, 283 (5400) : 387 - 390
  • [4] Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21(WAF1)
    Ball, KL
    Lain, S
    Fahraeus, R
    Smythe, C
    Lane, DP
    [J]. CURRENT BIOLOGY, 1997, 7 (01) : 71 - 80
  • [5] Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer
    Belinsky, SA
    Nikula, KJ
    Baylin, SB
    Issa, JPJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4045 - 4050
  • [6] Bender CM, 1998, CANCER RES, V58, P95
  • [7] Gene silencing - Methylation meets acetylation
    Bestor, TH
    [J]. NATURE, 1998, 393 (6683) : 311 - 312
  • [8] FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA
    CALDAS, C
    HAHN, SA
    DACOSTA, LT
    REDSTON, MS
    SCHUTTE, M
    SEYMOUR, AB
    WEINSTEIN, CL
    HRUBAN, RH
    YEO, CJ
    KERN, SE
    [J]. NATURE GENETICS, 1994, 8 (01) : 27 - 32
  • [9] Human DNA (cytosine-5) methyltransferase PCNA complex as a target for p21(WAF1)
    Chuang, LSH
    Ian, HI
    Koh, TW
    Ng, HH
    Xu, GL
    Li, BFL
    [J]. SCIENCE, 1997, 277 (5334) : 1996 - 2000
  • [10] Costello JF, 1996, CANCER RES, V56, P2405